Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China

Completed

Phase N/A Results N/A

Update History

28 Apr '17
Trial was updated to "N/A."
The gender criteria for eligibility was updated to "All."
A location was updated in Beijing.
New
The overall status was removed for Beijing Tiantan Hospital, Capital Medical University.
27 Jan '15
The description was updated.
New
This study is a multicentre prospective single-arm registry study and the protocol is approved by the ethics committee at the coordinating centre and by the local institutional review board at each participating centre. This study is initiated by the investigators, with 20 participating stroke centres (see online supplementary appendix II), and plans to recruit 300 consecutive patients who meet the inclusion and exclusion criteria. After the enrolment, all participants would be evaluated at baseline, day 4, day 30, months 6, months 9 and year 1 (see online supplementary appendix I). The Wingspan stent system is provided by the Boston Scientific company and the Apollo stent is provided by the MicroPort Company, but they will not participate in data collection, analysis, editing or make decisions about the publication. This study is sponsored and conducted by the Cerebrovascular Disease Center of Tiantan Hospital in addition to its responsibility for data analysis. An independent Data and Safety Monitoring Board (DSMB) oversees the conduction, safety and efficacy of the study.
Old
None.
A location was updated in Beijing.
New
The overall status was removed for Beijing Tiantan Hospital, Capital Medical University.